spacer
home > pmps > autumn 2018 > managing medication
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Managing Medication

Medication nonadherence is a serious public health issue. It costs the NHS approximately £500 million every year, as well as countless hours of work dealing with problems which arise due to patients not taking prescribed medications as directed. As the former US general surgeon, Dr C Everett Koop, stated, “drugs don’t work in patients who don’t take them.”

Across the UK, one billion items are prescribed and dispensed by pharmacists every year. However, one in five patients surveyed as part of the True Cost of Medication Non- Adherence report admitted to not taking their medication as prescribed. “Non-adherence is a big problem,” Ric Fordham, Professor of Applied Health and Economics at the University of East Anglia, UK, said in the study. “When patients don’t feel ill, or they start to feel better, they think there is no need for them to take their drugs anymore. Patients then don’t get the full benefit of them and that ends up reducing the cost effectiveness of the drugs.”

Nonadherence can be classified as intentional (when a patient actively decides not to take medication or follow treatment recommendations) or unintentional (which can be caused by misunderstanding the prescription requirements, an inability to access or administer prescribed medication, or simple forgetfulness). The National Institute for Health and Care Excellence states that nonadherence should not be considered as just the patient’s problem; ultimately, it represents a fundamental limitation in the delivery of healthcare.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Oliver Pittock is the Managing Director of pharmaceutical packaging specialist, Valley Northern. Oliver built his commitment to the healthcare and pharmacy supply business through seeing his father’s business grow throughout the 1970s. Moving to the Midlands in 1993, Oliver set up Valley Northern, which became a limited company in 2014.
spacer
Oliver Pittock
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nemera organized an expert review on the present and future of inhalation products

“Connectivity in every new inhalation device?” This topic was one of those discussed with different inhalation experts - Manfred Keller, Pascal Cavaillon and Henry Chrystyn – during a round table organized by Nemera in Paris to review the advantages and limitations of inhalation devices.
More info >>

White Papers

Planning the Execution of a Viral Clearance Study

Eurofins BioPharma Product Testing

Viral clearance studies are a necessary component of any regulatory submission for clinical trials or commercial product approval for all biopharmaceutical products. These studies are performed to evaluate the capability of the purification process to remove or inactivate viruses that could potentially contaminate the starting material. They are complex studies that require substantial financial and personnel resources, as well as specialized scientific expertise to perform. As such, viral clearance studies are often performed at a qualified contract testing laboratory rather than in-house. When multiple parties are involved in this process, clear communication and a comprehensive understanding of the approach and timeline is critical.
More info >>

 
Industry Events

LogiPharma 2019

9-11 April 2019, Montreux Music & Convention Centre

LogiPharma is the world’s leading pharma supply chain event. With over 950+ pharma supply chain leaders exclusively meeting in one place at one time, LogiPharma is THE meeting place to benchmark your business with the best pharma companies and shape the future of your industry.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement